Mehdi Gasmi
Geschäftsführer bei SparingVision SAS
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Stéphane Boissel | M | 56 |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | 4 Jahre |
| Laurent Fischer | M | 60 | 4 Jahre | |
| Peter Soparkar | M | 53 | 5 Jahre | |
| Clarence Machado | M | 60 | 7 Jahre | |
| Scott Whitcup | M | 64 | 4 Jahre | |
| Heikki Jouttijärvi | M | - | 4 Jahre | |
| Nathalie Trépo | F | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | 2 Jahre |
| Dawn Svoronos | F | 70 | 4 Jahre | |
| Mark Lupher | M | 53 | 5 Jahre | |
| Reed Tuckson | M | 73 | 3 Jahre | |
| Laurent Arthaud | M | 61 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| John Rakow | M | 67 | 3 Jahre | |
| Jim Scopa | M | 65 | 5 Jahre | |
| Joseph Papa | M | 68 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | 1 Jahre |
| Geoffroy de Ribains | M | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Frédéric Revah | M | 62 |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 14 Jahre |
| Karen Wagner | M | 54 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Jeanne Cunicelli | F | 57 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Owen Smith | M | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Dena House | F | - | 5 Jahre | |
| Benjamin Yerxa | M | 58 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Sabine Dandiguian | F | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Paul Sieving | M | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Bill Tan | M | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Leone Patterson | F | 61 | 5 Jahre | |
| Paul Cleveland | M | 67 | 4 Jahre | |
| Amber Salzman | M | 62 | 2 Jahre | |
| Hans Hull | M | 49 | 4 Jahre | |
| Thomas Chalberg | M | 46 | 9 Jahre | |
| Jennifer Cheng | M | 51 | 4 Jahre | |
| Steven Schwartz | M | 62 | 11 Jahre | |
| Mark Blumenkranz | M | 73 | 10 Jahre | |
| Christopher J. DeRespino | M | 43 | - | |
| Linda Bain | F | 53 | 1 Jahre | |
| Angela Thedinga | F | 42 | 2 Jahre | |
| Georgia Theofan | M | - |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | - |
| Katherine Bock | F | - | 1 Jahre | |
| Kate van Riper | F | - |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | - |
| Thomas Woiwode | M | 52 | 5 Jahre | |
| Rekha Hemrajani | F | 54 | 2 Jahre | |
| Valérie Soulier | M | 57 |
Université Claude Bernard Lyon 1
| 5 Jahre |
| Samuel Barone | M | 51 | 3 Jahre | |
| Myesha Lacy | F | - | - | |
| Jack Anthony Thrift | M | 58 | - | |
| Mitchell Finer | M | 65 | 13 Jahre | |
| Rupert D’Souza | M | 65 | 1 Jahre | |
| Eric Carter | M | 72 | 4 Jahre | |
| John McLaughlin | M | 72 | 2 Jahre | |
| Richard Spivey | M | 74 | - | |
| Jim Wang | M | - | 2 Jahre | |
| Elizabeth Alcamo | F | - | 2 Jahre | |
| Michael Swartzburg | M | 57 | - | |
| Géraldine Honnet | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 9 Jahre |
| Carol Hoang | M | - | - | |
| Guriqbal S. Basi | M | 67 | - | |
| Jon Williams | M | - | 1 Jahre | |
| Brigit Riley | M | 46 | 3 Jahre | |
| Linda Neuman | M | 59 | 1 Jahre | |
| Jean-Yves Blay | M | 61 |
Université Claude Bernard Lyon 1
| 3 Jahre |
| James Shahbazian | M | - | - | |
| Calvin Yu | M | 48 | 2 Jahre | |
| Aaron Osborne | M | 50 | 2 Jahre | |
| Phillip Eric Lee | M | 37 | 1 Jahre | |
| Julie Clark | M | - | - | |
| Thomas Leung | M | 43 | 2 Jahre | |
| David Warren Carter | M | 84 |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 3 Jahre |
| Roman Rubio | M | 53 | 2 Jahre | |
| Philippe Vuagnat | M | - |
Université Claude Bernard Lyon 1
| 3 Jahre |
| Matthias C. Kurth | M | 68 |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 1 Jahre |
| Patrick X. Lacchia | M | 54 |
Université Claude Bernard Lyon 1
| 1 Jahre |
| Eugene L. Step | M | 94 |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 6 Jahre |
| Inder Mohan Verma | M | 76 |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 3 Jahre |
| Raymond T. Bartus | M | - |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 11 Jahre |
| Dominick A. Vacante | M | - |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | - |
| Carlo Russo | M | 71 | - | |
| Lauren Glaser | F | - | - | |
| Joao Siffert | M | 60 |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 4 Jahre |
| Jeannette Fareh | M | - |
Université Claude Bernard Lyon 1
| 3 Jahre |
| Maurice J. Mezzino | M | - |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | - |
| Cedrick Favero | M | - |
Université Claude Bernard Lyon 1
| 4 Jahre |
| Andrea Loewen-Rodriguez | F | 57 |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 1 Jahre |
| Michael W. Fitzgerald | M | - | - | |
| Carolyn J. Bonebright | F | - |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 9 Jahre |
| Bong Koh | M | - | - | |
| Jean-Pierre Gotteland | M | 59 |
Université Claude Bernard Lyon 1
| 3 Jahre |
| Lisa Ann Melia | F | - |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | - |
| Anne Grand-Clément | F | 52 |
Université Claude Bernard Lyon 1
| 1 Jahre |
| Stephen Simes | M | 72 |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | 4 Jahre |
| Shirley Braun | M | - | 1 Jahre | |
| Athena Countouriotis | M | 52 | 1 Jahre | |
| Jacques Bodennec | M | - |
Université Claude Bernard Lyon 1
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 69 | 75,82% |
| Frankreich | 22 | 24,18% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mehdi Gasmi
- Persönliches Netzwerk